Transplants Podcasts Transplants RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

CMV treatment for stem cell transplant recipients: antivirals
Many infections can occur in cancer patients who are immunocompromised after receiving a stem cell transplant. In this interview, Genovefa Papanicolaou, MD, from Memorial Sloan Kettering Cancer Center... Author: VJHemOnc Added: 08/29/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 29, 2018 Category: Cancer & Oncology Source Type: podcasts

The importance of standardization in MRD testing
In this video, Oliver Ottmann, MD, FRCPath, of Cardiff University, Cardiff, UK, discusses the importance of allogeneic transplant in different populations of patients with Ph-positive acute lymphoblas... Author: VJHemOnc Added: 08/24/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 24, 2018 Category: Cancer & Oncology Source Type: podcasts

How much do bone marrow transplants really cost?
Prakash Satwani, MD, of Columbia University Medical Center, New York, NY, speaks to us about the true cost of bone marrow transplant ,and highlights potential alterations to the process and alternativ... Author: VJHemOnc Added: 08/24/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 24, 2018 Category: Cancer & Oncology Source Type: podcasts

Novel therapies for treating relapsed/refractory ALL
Speaking from the 2018 European Society for Blood and Marrow Transplantation (EBMT) Annual Meeting in Lisbon, Portugal, Daniel DeAngelo, MD, PhD, of the Dana-Farber Cancer Institute, Boston, MA, outli... Author: VJHemOnc Added: 08/24/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 24, 2018 Category: Cancer & Oncology Source Type: podcasts

Chronic GvHD therapy
Speaking from the 2018 European Society for Blood and Marrow Transplantation (EBMT) Annual Meeting in Lisbon, Portugal, Daniel Wolff, MD, PhD, of the University Hospital of Regensburg, Regensburg, Ger... Author: VJHemOnc Added: 08/23/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 23, 2018 Category: Cancer & Oncology Source Type: podcasts

Improving outcomes after transplant in AML
Charles Craddock, CBE, FRCP (UK), FRCPath, DPhil, of the University of Birmingham, Birmingham, UK, discusses how we can improve outcomes after transplant in acute myeloid leukemia (AML). Prof. Craddoc... Author: VJHemOnc Added: 08/21/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 21, 2018 Category: Cancer & Oncology Source Type: podcasts

The role of the pharmacist in transplant
Speaking from the 2018 Hematology/Oncology Pharmacy Association (HOPA) Annual Conference, held in Denver, CO, Jeanne McCarthy-Kaiser, PharmD, BCOP, of the University of Washington Medical Center, Seat... Author: VJHemOnc Added: 08/21/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 21, 2018 Category: Cancer & Oncology Source Type: podcasts

Benefits of performing outpatient transplant
Speaking from the 2018 Hematology/Oncology Pharmacy Association (HOPA) Annual Conference, held in Denver, CO, Jeanne McCarthy-Kaiser, PharmD, BCOP, of the University of Washington Medical Center, Seat... Author: VJHemOnc Added: 08/21/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 21, 2018 Category: Cancer & Oncology Source Type: podcasts

Transplant trials in myeloma: EMN02 and BMT CTN 0702
Philip McCarthy, MD, of Roswell Park Comprehensive Cancer Center, Buffalo, NY, discusses two Phase III multiple myeloma (MM) transplantation studies that have been performed: EMN02 (NCT01208766) and B... Author: VJHemOnc Added: 08/16/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 16, 2018 Category: Cancer & Oncology Source Type: podcasts

Improving outcomes for R/R DLBCL with polatuzumab vedotin
Patients with relapsed, transplant ineligible diffuse large B-cell lymphoma (DLBCL) face extremely poor outcomes. In this video, recorded at the 23rd Congress of the European Hematology Association (E... Author: VJHemOnc Added: 08/07/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 7, 2018 Category: Cancer & Oncology Source Type: podcasts

Rituximab maintenance key to outcome improvement in mantle cell lymphoma
Mantle cell lymphoma (MCL) outcomes have improved in recent years as a result of an influx of improved treatments, including rituximab, high dose Ara-C and stem cell transplant. As Marek Trneny, MD, P... Author: VJHemOnc Added: 08/07/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 7, 2018 Category: Cancer & Oncology Source Type: podcasts

Defibrotide: still early days but a promising outlook for veno-occlusive disease
Defibrotide has previously been studied in post-stem cell transplant patients with veno-occlusive disease with a suitable investigational new drug (IND). Speaking from the 23rd Congress of the Europea... Author: VJHemOnc Added: 08/07/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 7, 2018 Category: Cancer & Oncology Source Type: podcasts

FDA Drug Safety Podcast: FDA warns about increased risk of cancer relapse with long-term use of azithromycin (Zithromax, Zmax) antibiotic after donor stem cell transplant
On August 3, 2018 FDA warned that the antibiotic azithromycin (brand name Zithromax, Zmax) should not be given long-term to prevent a certain inflammatory lung condition in patients with cancers of the blood or lymph nodes who undergo a donor stem cell transplant. (Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - August 6, 2018 Category: Drugs & Pharmacology Authors: U.S. Food and Drug Administration, Center for Drug Evaluation and Research Source Type: podcasts

ADD-What are the immediate and long-term side effects of an autologous stem cell transplant (ASCT)?
In this video, Dr. Brian G.M. Durie explains how high-dose melphalan therapy that precedes an ASCT may cause some side effects and how an ASCT itself may result in some low-risk complications.<br /><br />The ... Author: InternationalMyelomaFoundation Added: 08/06/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 6, 2018 Category: Cancer & Oncology Source Type: podcasts

CAR T-cells improve response and CR rates in R/R DLBCL
In relapsed/refractory diffuse large B-cell lymphoma (DLBCL), response rates are poor for salvage treatments and autologous stem cell transplants. Here, Christian Gisselbrecht, MD, of the Hpital Sain... Author: VJHemOnc Added: 07/31/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 31, 2018 Category: Cancer & Oncology Source Type: podcasts